ADDE a major supplier in $100M investment

The Prime Minister, Malcolm Turnbull, addressing a business breakfast at the Australian High Commission in London, welcomed the announcement by Mr Pascal Soriot, Chief Executive of AstraZeneca, of a $100 million investment in its Australian manufacturing facility.

AstraZeneca, a leading manufacturer of pharmaceuticals in Australia, will use the investment to fund three new specialised production lines at its Sydney facility for innovative respiratory medicines.

Bayswater specialist machine designers of industrial automation solutions, Andrew Donald Design Engineering (ADDE), will build each new production line with the machines taking a team of 36 people over 12 months to produce.

Pascal Soriot said the latest investment comes on the back of another $100 million invested over the last few years in the facility. 

“That is really a centre of excellence for us, for the manufacture of inhaler products for the treatment of asthma and COPD [chronic obstructive pulmonary disease].”

ADDE has been a supplier of choice to AstraZeneca for many years, and manufactured the company’s eight existing specialised lines at the North Ryde site.

“Through this incremental investment, we intend to generate about $2.6 billion of exports out of Australia to a great variety of markets including China.

These products are growing very rapidly and we expect to generate even more investments in jobs in Australia over the next few years.

“It’s really high quality manufacturing, really specialised manufacturing in the pharmaceutical industry and it’s our centre of excellence for the world,” Mr Soriot said. Each production line has the capacity to produce over 70 million units per year of Pulmicort respules, a medicine for patients with asthma.

It is predicted that by 2025 AstraZeneca’s site will be producing over one billion respules per year.

Mark Morgan, Manufacturing Director of AstraZeneca Australia, said the machinery is a credit to Australian engineering excellence and its performance can be attributed to the company’s workforce who achieves significant increases in productivity and efficiency out of the machines.

Palletiser with robotic arm

This new ADDE project follows on from its successful working relationship with Baxter Laboratories in Boronia, which became the first company to use an ADDE-designed end-of-line automated palletising system that incorporates a collaborative robot.

The Zero Footprint Palletiser (ZFP) takes no more space than a pallet on the floor and an operator, and allows manufacturers to generate greater efficiency and safety across operations, while also enabling employees to work closely in collaboration with the palletiser. Baxter Laboratories uses the ZFP, which integrates a robotic arm, to assist in packing Aerogard insect repellent spray bottles into a semi-automatic carton assembler, then into boxes on a pallet ready for distribution.

Additional information from The Australian

www.adde.com.au